Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value per share (VRCA) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2025 to Q4 2025

Type / Class
Equity / Common Stock, $0.0001 par value per share
Symbol
VRCA on Nasdaq
Shares outstanding
16,075,855
Price per share
$8.30
All holders as of 31 Dec 2025
Q4 2025
Total 13F shares
2,435,253
Total reported value
$20,213,699
% of total 13F portfolios
0%
Share change
+1,684,586
Value change
+$14,037,110
Number of holders
33
Price from insider filings
$8.30
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value per share (VRCA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Manning Paul B 50% $28,437,789 8,056,031 Paul B Manning 25 Nov 2025
Caligan Partners LP 10% 0% $43,635,492 6,503,054 0% Caligan Partners LP 26 Dec 2025
Affinity Asset Advisors, LLC 5.5% +0.6% $7,346,762 884,172 0% Affinity Asset Advisors, LLC 22 Jan 2026
ARMISTICE CAPITAL, LLC 6.8% $2,754,858 639,193 Armistice Capital, LLC 30 Sep 2025

As of 31 Dec 2025, 33 institutional investors reported holding 2,435,253 shares of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value per share (VRCA). This represents 15% of the company’s total 16,075,855 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value per share (VRCA) together control 15% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
Affinity Asset Advisors, LLC 4.4% 707,338 0.42% $5,877,979
Velan Capital Investment Management LP 2.9% 471,559 2.3% $3,918,655
Stonepine Capital Management, LLC 2.2% 353,669 2.3% $2,938,989
Kalehua Capital Management LLC 1.5% 235,779 0% 2% $1,959,323
VANGUARD GROUP INC 0.86% 138,194 -39% 0% $1,148,392
JANE STREET GROUP, LLC 0.63% 101,722 0% $845,310
MARSHALL WACE, LLP 0.53% 85,173 0% $707,786
GEODE CAPITAL MANAGEMENT, LLC 0.42% 67,659 0% 0% $562,388
Squarepoint Ops LLC 0.21% 33,270 0% $276,474
Sovran Advisors, LLC 0.2% 32,658 -56% 0.02% $248,527
RENAISSANCE TECHNOLOGIES LLC 0.16% 26,400 -9.6% 0% $219,384
Mariner, LLC 0.15% 24,544 -0.02% 0% $203,961
STATE STREET CORP 0.15% 23,481 +14% 0% $195,127
OMERS ADMINISTRATION Corp 0.14% 22,600 0% $187,806
MORGAN STANLEY 0.14% 22,009 +1.5% 0% $182,894
GOLDMAN SACHS GROUP INC 0.12% 18,621 0% $154,741
HRT FINANCIAL LP 0.11% 17,356 0% $144,000
Legacy Trust 0.11% 17,234 0.03% $143,215
Walleye Capital LLC 0.09% 15,240 0% $126,644
BECK MACK & OLIVER LLC 0.07% 12,000 0% $99,720
BlackRock, Inc. 0.04% 5,685 -7.5% 0% $47,243
Capital Analysts, LLC 0.01% 1,500 0% 0% $12,000
Fortitude Family Office, LLC 0% 608 0% $5,052
Salomon & Ludwin, LLC 0% 290 0% 0% $2,572
New England Capital Financial Advisors LLC 0% 200 0% 0% $1,662

Institutional Holders of Verrica Pharmaceuticals Inc. - Common Stock, $0.0001 par value per share (VRCA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 2,435,253 $20,213,699 +$14,037,110 $8.31 33
2025 Q3 2,468,945 $10,583,119 +$10,479,755 $4.31 31
2025 Q2 194,004 $102,830 +$102,830 $0.53 4